NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
$147.97 -3.02 (-2.0001%)
Analysed NOVARTIS AG-SPONSORED ADR (NVS:NYSE) News Sources
This Biotech Stock Is Up 460% Over the Past Year. Why Analysts See It Rising Higher.
21-04-2026
yahoo.com
BIIB Inks Deal to Acquire Rights to Felzartamab in China, Stock Up
21-04-2026
yahoo.com
AstraZeneca's Ultomiris Meets Goal in Rare Kidney Disease Study
21-04-2026
yahoo.com
Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others
20-04-2026
yahoo.com
Assessing Novartis (SWX:NOVN) Valuation After Recent Share Price Moves And Long Term Returns
19-04-2026
yahoo.com
Better Pharma Dividend Stock: Novartis vs. Merck
17-04-2026
fool.com
3 Best Vanguard Dividend ETFs for Reliable Passive Income in 2026
17-04-2026
yahoo.com
Thyroid Eye Disease Treatment Market Research Report 2026 Featuring Amgen, Viridian, Novartis, Roche, Sanofi, AbbVie, and Teva with Analyst Recommendations and Forecasts to 2031
16-04-2026
yahoo.com
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
15-04-2026
yahoo.com
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight
15-04-2026
yahoo.com
What is the current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The current price of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is $147.97.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) absolute price change since previous trading day?
The absolute price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is $-3.02.
NOVARTIS AG-SPONSORED ADR (NVS:NYSE) percentage price change since previous trading day?
The percentage price change of NOVARTIS AG-SPONSORED ADR (NVS:NYSE) since the previous trading day is -2.0001%.
What is the most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent average sentiment score for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is 78 out of 100.
What is the most recent average sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE)?
The most recent sentiment for NOVARTIS AG-SPONSORED ADR (NVS:NYSE) is .
SEC-8K** Filing Available For NOVARTIS AG-SPONSORED ADR (NVS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.